Capricorn Energy PLC (CNE)
London Exchange · UK · prices in GBX · close of 22 Oct 2026
Key indicators
| Last close | GBX 424.00 |
|---|---|
| 52-week range | 181.80 – 450.00 |
| Return, 1 month / 3 months | +10.4% / +19.8% |
| Return, 1 year / 3 years | +118.6% / +113.8% |
| Trend | Uptrend |
| RSI (14) | 60 |
| Volatility (1 year) | 47.1% |
| Worst drawdown (1 year) | -15.9% |
| Average daily value traded | 72.31M GBX |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Capricorn Energy is an oil and gas company based in the United Kingdom. It explores for and produces hydrocarbons, with its main producing operations in Egypt, where it supplies natural gas and liquids to domestic and international markets. The company also holds exploration and development interests in other regions. Its customers are mainly energy buyers and state or partner organisations in the countries where it operates, and its business centres on finding, developing and extracting oil and gas reserves.
On this site Capricorn Energy PLC appears as a stock on the London Exchange (UK), code CNE, with prices in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Capricorn Energy PLC (CNE) trades on the London Exchange in UK. It last closed at GBX 424.00 on 22 October 2026.
Its price-based Market X-Ray is 81 out of 100 (a strong price profile), ranking 40 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 118.6% and over the last three months it rose 19.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 89 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 31.6% | ||
| From 52-week high | -5.8% | ||
| Momentum | 92 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 19.8% | ||
| 6-month return | 35.9% | ||
| 12-month return, skipping the last month | 97.9% | ||
| Stability (higher is calmer) | 57 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 47.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -15.9% | ||
| Liquidity | 87 · Strong | Trades actively. | |
| Average daily value traded | 72.31M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −0.7% |
|---|---|
| 1 month | +10.4% |
| 3 months | +19.8% |
| 6 months | +35.9% |
| 1 year | +118.6% |
| 3 years | +113.8% |
| 5 years | −43.8% |
Signals
| 50-day / 200-day average | 391.78 / 322.16 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 6.79 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 24 May 2024 | GBP 0.4300 |
| 6 Oct 2023 | GBP 0.3733 |
| 16 May 2023 | GBP 1.1500 |
| 11 Jan 2021 | GBP 0.2708 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.